Steph & Co’s Maravai LifeSciences MRVI Stock Holding History

Steph & Co’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,389	Closed	-$73.9K	–	279
2023 Q3	$73.9K	Buy	7,389 +321	+5%	+$3.52K	0.04%	159
2023 Q2	$87.9K	Buy	7,068 +314	+5%	+$4.24K	0.05%	148
2023 Q1	$94.6K	Hold	6,754	–	–	0.06%	144
2022 Q4	$97K	Buy	+6,754	New	+$106K	0.06%	142

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Steph & Co's MRVI Position: Q4 2023 in Review

Steph & Co sold out of Maravai LifeSciences (MRVI) in Q4 2023, closing a stake of 7,389 shares — an estimated $73.9K sold.

Steph & Co first reported a position in MRVI in Q4 2022 and held it in 4 quarters. The position peaked at $97K in Q4 2022. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

Steph & Co reported no remaining Maravai LifeSciences position as of Q4 2023 after selling out during the quarter.
Steph & Co sold 7,389 Maravai LifeSciences shares in Q4 2023, an estimated $73.9K.
Steph & Co first reported a position in Maravai LifeSciences in Q4 2022 and held it in 4 quarters.
Steph & Co's Maravai LifeSciences position peaked at $97K in Q4 2022.
223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on Steph & Co's 13F filing for Q4 2023, filed 31 Jan 2024.